Physician profile
John C Cranham
NPI 1215197595
$172,036.29
in general payments reported to CMS, 2019-2025
13 companies · $53K in 2025
The $53K reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $58K · 2021: $27K · 2022: $12K · 2023: $1,268 · 2024: $22K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $69K · Travel and Lodging: $4,108 · Food and Beverage: $2,579 · Entertainment: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $68,695.00 |
| Travel and Lodging | $4,108.28 |
| Food and Beverage | $2,579.29 |
| Entertainment | $814.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $74,354.35 | 2023-2025 | |
| Carestream Dental, LLC | $72,738.00 | 2020-2021 | |
| Whip Mix Corporation | $18,044.54 | 2021-2023 | |
| Henry Schein, INC. | $5,088.65 | 2022 | |
| Ivoclar Vivadent, INC. | $899.44 | 2020-2024 | |
| Align Technology, INC. | $404.62 | 2021-2025 | Invisalign, Itero Element 2, Itero Element 5d Plus |
| Keystone Dental INC. | $239.47 | 2023 | |
| Straumann USA LLC | $101.64 | 2025 | |
| 3shape INC | $62.61 | 2022 | |
| Solventum Corporation | $34.55 | 2025 | 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Scotchbond |
| Nobel Biocare USA | $30.75 | 2021 | |
| 3m Company | $23.33 | 2022 | |
| Dentsply Sirona INC | $14.34 | 2023 | Waveone Gold Conform Fit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cranham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.